December 21, 2022
October 11, 2022
Learn about our latest Annual Report, attendance at ASTMH annual meeting, signing of the Kigali Declaration, job opportunities and more.
October 1, 2022
August 12, 2022
June 24, 2022
Learn about events, US charity status, board expansion and new funding
June 23, 2022
Learn about progress in clinical development, team expansion, awards and more
March 1, 2022
Mark Sullivan, Founder and CEO of Medicines Development for Global Health (MDGH), has been awarded the Officer of the Order of Australia (AO), one of the highest civilian honours in Australia.
January 25, 2022
Learn about new lymphatic filariasis data for moxidectin, progress in clinical development, team expansion, awards and more
December 18, 2021
Learn about MDGH's expanded footprint, its progress in clinical development, a social impact investment opportunity, and the nominations for the Prix Galien Award for 2021.
September 1, 2021
A look at the 2020 MDGH Annual Report, clinical development updates, and the development of a new formulation of moxidectin for children.
June 1, 2021
Learn more about MDGH's plans for its new investigational treatment for tuberculosis and leprosy types 2 reactions
March 1, 2021
Have you ever wondered what the letters and numbers stamped on the surface of a pill mean?
January 1, 2021
Amgen licenses AMG 634, an investigational treatment for tuberculosis and leprosy, to medicines development for global health...
December 22, 2020
The Mectizan (ivermectin) Expert Committee states that new in vitro data are not sufficient to indicate clinical benefit to reduce viral loads in COVID-19 patients...
April 8, 2020
January 30, 2020 marks the first ever World Neglected Tropical Disease Day. It is billed as 'A New Day in the Fight Against NTDs' and kicks off a decisive year in the fight against NTDs...
January 30, 2020
Mark Sullivan, Managing Director and Founder of Medicines for Global Health, was awarded one of EY Australia's "Entrepreneur of the Year" awards in the social category for his work in establishing MDGH...
November 5, 2019
Significant portion of proceeds will be reinvested in neglected disease research and control efforts, fully realizing the original intent of this important public health funding mechanism...
August 9, 2019
Awarded annually, the Prix Galien Award recognizes outstanding achievements in improving the global human condition through the development of innovative drugs and other treatments...
July 18, 2019
Please try again.
Find what you need to help spread the word about new and improved treatments for neglected diseases